The Perindopril in Elderly People with Chronic Heart Failure study failed to show that perindopril could reduce long-term mortality or morbidity among elderly people with diastolic with heart failure.

Learn everything you need to know about Perindopril-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side effects, precautions, warnings ...

Perindopril is a long-acting ACE inhibitor, prescribed for high blood pressure, heart attack and heart failure. We recommend consulting your doctor to verify the information presented on this page or ...

For a follow-up discussion of the ADVANCE trial, see ADVANCE reinforces message to aggressively treat blood pressure in diabetics The study, which is being presented today at the European Society of ...

PICXEL was designed to evaluate the effects of long-term administration of a very low-dose combination of perindopril plus indapamide (perindopril/indapamide) vs ...

A fixed combination of perindopril (an ACE inhibitor) plus indapamide (a diuretic), available under the brand name Preterax, was evaluated in a randomized trial (Lancet. 2007;370:829-840). Patients ...

Continuing a trend in secondary prevention, the FDA has approved perindopril for the treatment of patients with stable coronary artery disease to reduce the risk of cardiovascular mortality and ...

The aim of our study was to compare glucose homeostasis, serum lipid profile, fibrinolytic activity, albumin excretion rate (AER), and homocysteine (Hct) in patients with mild hypertension and type II ...

The "high tissue" ACE inhibitor, perindopril significantly reduces the risk of death, hospitalisation for HF and cardiac remodeling in elderly post MI patients with preserved LV function according to ...

What to do: If your bottle of ezetimibe 10 mg tablets contains any perindopril 4 mg tablets, or if you are unsure, return it to your pharmacy immediately. If you are unable to return your tablets to ...

Background: Physical function and exercise capacity decline with age and are a major source of disability in older people. Recent evidence suggests a potential role for the renin–angiotensin system in ...

BERKELEY, Calif., July 3, 2013 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq:XOMA), a leader in the discovery and development of therapeutic antibodies, announced today it has transferred U.S.